SCHEMBL1100635

SCHEMBL1100635

COc1ccc(Br)c(CN(c2sc3ccccc3c2Br)S(=O)(=O)c2ccccc2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 1/20 0.42
KEAP1 Q14145 5/20 0.41
NFE2L2 Q16236 5/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 3/20 0.41
PGR P06401 2/20 0.41
LMNA P02545 2/20 0.40
TAS2R14 Q9NYV8 1/20 0.39
ALDH1A1 P00352 2/20 0.39
NPC1 O15118 1/20 0.39
MAPT P10636 1/20 0.39
RAB9A P51151 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
NPSR1 Q6W5P4 2/20 0.38
NR3C1 P04150 1/20 0.38
MMP1 P03956 2/20 0.38
MMP9 P14780 2/20 0.38
MMP13 P45452 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1099256 0.86 TRPM8 (0.52) TRPM8KEAP1NFE2L2PGRLMNA
SCHEMBL1100782 0.86 PGR (0.50) TRPM8KEAP1NFE2L2PGRLMNA
SCHEMBL1100732 0.84 TAS2R14 (0.44) TRPM8MEN1KMT2ALMNATAS2R14
SCHEMBL1099528 0.84 ALDH1A1 (0.39) TRPM8MEN1KMT2AKDM4ELMNA
SCHEMBL1098198 0.81 TRPM8 (0.44) TRPM8KDM4ETAS2R14ALDH1A1MAPT
SCHEMBL1098673 0.81 TRPM8 (0.41) TRPM8KEAP1NFE2L2MEN1KMT2A
SCHEMBL1098790 0.79 TRPM8 (0.47) TRPM8KEAP1NFE2L2MEN1KMT2A
SCHEMBL1098841 0.78 TRPM8 (0.42) TRPM8KEAP1NFE2L2MEN1KMT2A
SCHEMBL1100743 0.78 NR1I2 (0.50) TRPM8KEAP1NFE2L2ALDH1A1NPSR1
SCHEMBL1098799 0.78 C1R (0.44) TRPM8KEAP1NFE2L2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9434711-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, N.V. (BE) 2016-09-06 US disclosed
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-10-23 US disclosed
US-8809327-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2014-08-19 US disclosed
EP-2183239-B1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2012-08-22 EP disclosed
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS BRANUM SHAWN T (US) 2012-07-26 US disclosed
US-8153682-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2012-04-10 US disclosed
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885KEAP1 2521/4885NFE2L2 2965/4885
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885KEAP1 2521/4885NFE2L2 2965/4885
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885KEAP1 2521/4885NFE2L2 2965/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.